SpringerLink
Log in

Synergistic antitumor efficacy of suicide/ePNP gene and 6-methylpurine 2′-deoxyriboside via Salmonella against murine tumors

  • Original Article
  • Published:
Cancer Gene Therapy Submit manuscript

Abstract

Some anaerobes and facultative anaerobes have been used in tumor-specific gene therapy by reason of their selective growth in tumors. In this work, we aimed to evaluate the anticancer efficacy of attenuated Salmonella typhimurium as a carrier to deliver the Escherichia coli purine nucleoside phosphorylase (ePNP) gene for GDEPT (gene-directed enzyme-prodrug therapy). A live attenuated purine-auxotrophic strain of S. typhimurium (SC36) was used to carry the pEGFP-C1-ePNP vector that contains a green fluorescent protein (GFP) and an ePNP gene under the control of the human cytomegalovirus (CMV) promoter. The function of the ePNP expression vector was confirmed in vitro using the enzymic conversion of 6-methylpurine 2′-deoxyriboside (MePdR) into 6-methylpurine. We also observed a high bystander effect induced by the ePNP/MePdR system with a very low proportion (1%) of ePNP-positive cells. The killing effect and increased apoptosis induced by SC/ePNP (SC36 carrying the ePNP expression vector) infection were detected by cytotoxicity assay and PI staining flow cytometry analysis, in combination with MePdR administration. Furthermore, SC/ePNP was administered orally into mice bearing melanomas or pulmonary tumors, and its anti-tumor effect was evaluated. When the tumor was huge (500 mm3) at the beginning of MePdR administration, SC/ePNP plus MepdR significantly inhibited tumor growth by about 59–80% and prolonged survival of mice. Complete tumor regression and long-term cure were achieved by MePdR administration, even when the tumor was large (100 mm3) at the beginning of MePdR treatment. Our data support a hopeful view that tumor-targeting SC36 could improve antitumor efficacy of the ePNP/MePdR system due to its preferential accumulation and anticancer activity in tumors.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price includes VAT (Germany)

Instant access to the full article PDF.

Institutional subscriptions

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7
Figure 8

Similar content being viewed by others

References

  1. Sarkar D, Su ZZ, Vozhilla N, Park ES, Gupta P, Fisher PB . Dual cancer-specific targeting strategy cures primary and distant breast carcinomas in nude mice. Proc Natl Acad Sci USA 2005; 102: 14034–14039.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Pawelek JM, Low KB, Bermudes D . Tumor-targeted Salmonella as a novel anticancer vector. Cancer Res 1997; 57: 4537–4544.

    CAS  PubMed  Google Scholar 

  3. Low KB, Ittensohn M, Le T, Platt J, Sodi S, Amoss M et al. Lipid A mutant Salmonella with suppressed virulence and TNFα induction retain tumor-targeting in vivo. Nat Biotechnol 1999; 17: 37–41.

    Article  CAS  PubMed  Google Scholar 

  4. Pawelek JM, Low KB, Bermudes D . Bacteria as tumour-targeting vectors. Lancet Oncol 2003; 4: 548–556.

    PubMed  Google Scholar 

  5. Clairmont C, Lee KC, Pike J, Ittensohn M, Low KB, Pawelek J et al. Biodistribution and genetic stability of the novel antitumor agent VNP20009, a genetically modified strain of Salmonella typhimurium. J Infect Dis 2000; 181: 1996–2002.

    Article  CAS  PubMed  Google Scholar 

  6. Steven A, Rosenberg SA, Spiess PJ, Kleiner DE . Antitumor effects in mice of the intravenous injection of attenuated Salmonella typhimurium. J Immunother 2002; 25: 218–225.

    Article  Google Scholar 

  7. Saltzman DA, Katsanis E, Heise CP, Hasz DE, Vigdorovich V, Kelly SM et al. Antitumor mechanisms of attenuated Salmonella typhimurium containing the gene for human interleukin-2: a novel antitumor agent? J Ped Surg 1997; 32: 301–306.

    Article  CAS  Google Scholar 

  8. Sorscher EJ, Peng S, Bebok Z, Allan PW, Bennett Jr LL, Parker WB . Tumor cell bystander killing in colonic carcinoma utilizing the E. coli Deo D gene and generation of toxic purines. Gene Ther 1994; 1: 233–238.

    CAS  PubMed  Google Scholar 

  9. Jensen KF, Nygaard P . Purine nucleoside phosphorylase from Escherichia coli and Salmonella typhimurium. Purification and some properties. Eur J Biochem 1975; 51: 253–265.

    Article  CAS  PubMed  Google Scholar 

  10. Ealick SE, Greenhough TJ, Babu YS, Carter DC, Cook WJ, Rule SA et al. Three-dimensional structure of human erythrocytic purine nucleoside phosphorylase at 3.2 A resolution. J Biol Chem 1990; 265: 1812–1820.

    CAS  PubMed  Google Scholar 

  11. Mao C, Cook WJ, Zhou M, Koszalka GW, Krenitsky TA, Ealick SE . The crystal structure of Escherichiacoli purine nucleoside phosphorylase: a comparison with the human enzyme reveals a conserved topology. Structure 1997; 5: 1373–1383.

    Article  CAS  PubMed  Google Scholar 

  12. Secrist III JA, Parker WB, Allan PW, Bennett Jr LL, Waud WR, Truss JW et al. Gene therapy of cancer: activation of nucleoside prodrugs with E. coli purine nucleoside phosphorylase. Nucleosides Nucleotides 1999; 18: 745–757.

    Article  CAS  PubMed  Google Scholar 

  13. Bzowska A, Kulikowska E, Shugar D . Purine nucleoside phosphorylases: properties, functions and clinical aspects. Pharmacol Ther 2000; 88: 349–425.

    Article  CAS  PubMed  Google Scholar 

  14. Hughes B, Parker WB, Gadi VK, Garver RI, Sorscher EJ . Tumor specific killing with high bystander toxicity using the human tyrosinase promoter to express the E. coli PNP gene. Cancer Res 1995; 55: 3339–3345.

    CAS  PubMed  Google Scholar 

  15. Lockett LJ, Molloy PL, Russell PJ, Both GW . Relative efficiency of tumor cell killing in vitro by two enzyme-prodrug systems delivered by identical adenovirus vectors. Clin Cancer Res 1997; 3: 2075–2080.

    CAS  PubMed  Google Scholar 

  16. Park BJ, Brown CK, Hu Y, Alexander HR, Horti J, Raje S et al. Augmentation of melanoma-specific gene expression using a tandem melanocyte-specific enhancer results in increased cytotoxicity of the purine nucleoside phosphorylase gene in melanoma. Hum Gene Ther 1999; 10: 889–898.

    Article  CAS  PubMed  Google Scholar 

  17. Gadi VK, Alexander SD, Kudlow JE, Allan P, Parker WB, Sorscher EJ . In vivo sensitization of ovarian tumors to chemotherapy by expression of E. coli purine nucleoside phosphorylase in a small fraction of tumor cells. Gene Ther 2000; 7: 1738–1743.

    Article  CAS  PubMed  Google Scholar 

  18. Krohne TU, Shankara S, Geissler M, Roberts BL, Wands JR, Blum HE et al. Mechanisms of cell death induced by suicide genes encoding purine nucleoside phosphorylase and thymidine kinase in human hepatocellular carcinoma cells in vitro. Hepatology 2001; 34: 511–518.

    Article  CAS  PubMed  Google Scholar 

  19. Da Costa L, Jen J, He TC, Kinzler KW, Vogelstein B . Converting cancer genes into killer genes. Proc Natl Acad Sci 1996; 93: 4192–4196.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Nestler U, Heinkelein M, Lucke M, Meixensberger J, Scheurlen W, Kretschmer A et al. Foamy virus vectors for suicide gene therapy. Gene Ther 1997; 4: 1270–1277.

    Article  CAS  PubMed  Google Scholar 

  21. Parker WB, King SA, Allan PW, Bennett Jr LL, Secrist III JA, Montgomery JA et al. In vivo gene therapy of cancer with E. coli purine nucleoside phosphorylase. Hum Gene Ther 1997; 8: 1637–1644.

    Article  CAS  PubMed  Google Scholar 

  22. Hughes BW, King SA, Allan PW, Parker WB, Sorscher EJ . Cell to cell contact is not required for bystander cell killing by E. coli purine nucleoside phosphorylase. J Biol Chem 1998; 273: 2322–2328.

    Article  CAS  PubMed  Google Scholar 

  23. Bharara S, Sorscher EJ, Gillespie GY, Lindsey JR, Hong JS, Curlee KV et al. Antibiotic-mediated chemoprotection enhances adaptation of E. coli PNP for herpes simplex virus based glioma therapy. Hum Gene Ther 2005; 16: 1–9.

    Article  Google Scholar 

  24. Martiniello-Wilks R, Dane A, Jeyakumar G, Mortensen E, Shaw JM, Wang X-Y et al. Gene-directed enzyme prodrug therapy for prostate cancer in a mouse model that imitates the development of human disease. J Gene Med 2004; 6: 43–54.

    Article  CAS  PubMed  Google Scholar 

  25. Hughes BW, Wells AH, Bebok Z, Gadi VK, Garver Jr RI, Parker WB et al. Bystander killing of melanoma cells using the human tyrosinase promoter to express the Escherichia coli purine nucleoside phosphorylase gene. Cancer Res 1995; 55: 3339–3345.

    CAS  PubMed  Google Scholar 

  26. Deharvengt S, Wack S, Uhring M, Aprahamian M, Hajri A . Suicide gene/prodrug therapy for pancreatic adenocarcinoma by E. coli purine nucleoside phosphorylase and 6-methylpurine 2′-deoxyriboside. Pancreas 2004; 28: e54–e64.

    Article  PubMed  Google Scholar 

  27. Deharvengt S, Wack S, Aprahamian M, Hajri A . Transcriptional tumor-selective promoter targeting of E. coli purine nucleoside phosphorylase for pancreatic cancer suicide gene therapy. J Gene Med 2005; 7: 672–680.

    Article  CAS  PubMed  Google Scholar 

  28. Cai X, Zhou J, Lin J, Sun X, Xue X, Li C . Experimental studies on PNP suicide gene therapy of hepatoma. J Huazhong Univ Sci Technolog Med Sci 2005; 25: 178–181.

    Article  CAS  PubMed  Google Scholar 

  29. Cai XK, Zhou JL, Zhou HJ, Zhang L, Wu JH, Lin JS . Killing effect of PNP/MeP-dR suicide gene system driven by an AFP promoter AF0.3 on AFP-positive hepatoma cells. Ai Zheng 2006; 25: 1334–1339. Chinese.

    CAS  PubMed  Google Scholar 

  30. Kikuchi E, Menendez S, Ozu C, Ohori M, Cordon-Cardo C, Logg CR et al. Delivery of replication-competent retrovirus expressing Escherichia coli purine nucleoside phosphorylase increases the metabolism of the prodrug, fludarabine phosphate and suppresses the growth of bladder tumor xenografts. Cancer Gene Ther 2007; 14: 279–286.

    Article  CAS  PubMed  Google Scholar 

  31. Graves LM, Swaminathan B . Universal bacterial DNA isolation procedure. In: Persing DH, Smith TR, Tenover FC, White TJ (eds). Diagnostic Molecular Microbiology, Washington: American Society for Microbiology, 1993, pp 617–621.

    Google Scholar 

  32. Roth JR . Genetic techniques in studies of bacterial metabolism. Methods Enzymol 1970; 17: 3–35.

    Article  Google Scholar 

  33. Tong G, Wenzhou L, Shenghua L, **aohui L, Daming R, Xuhui H et al. Enzymatic synthesis of 6-methylpurine-20-deoxyriboside by recombinant purine nucleoside phosphorylase. Ind Microbiol 2007; 37: 8–13.

    Google Scholar 

  34. Mosmann T . Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983; 65: 55.

    Article  CAS  PubMed  Google Scholar 

  35. Sasaki DT, Dumas SE, Engleman EG . Discrimination of viable and non-viable cells using propidium iodide in two color immunofluorescence. Cytometry 1987; 8: 413–420.

    Article  CAS  PubMed  Google Scholar 

  36. Tanaka T, Kanai F, Okabe S, Yoshida Y, Wakimoto H, Hamada H et al. Adenovirus-mediated prodrug gene therapy for carcinoembryonic antigenproducing human gastric carcinoma cells in vitro. Cancer Res 1996; 56: 1341–1345.

    CAS  PubMed  Google Scholar 

  37. Theys J, Landuyt W, Nuyts S, Van Mellaert L, van Oosterom A, Lambin P et al. Specific targeting of cytosine deaminase to solid tumors by engineered Clostridiumacetobutylicum. Cancer Gene Ther 2001; 8: 294–297.

    Article  CAS  PubMed  Google Scholar 

  38. Li X, Fu GF, Fan YR, Liu WH, Liu XJ, Wang JJ et al. Bifidobacterium adolescentis as a delivery system of endostatin for cancer gene therapy: selective inhibitor of angiogenesis and hypoxic tumor growth. Cancer Gene Ther 2003; 10: 105–111.

    Article  CAS  PubMed  Google Scholar 

  39. Schoen C, Stritzker J, Goebel W, Pilgrim S . Bacteria as DNA vaccine carriers for genetic immunization. Int J Med Microbiol 2004; 294: 319–335.

    Article  CAS  PubMed  Google Scholar 

  40. Brown SP, Cornell SJ, Sheppard M, Grant AJ, Maskell DJ, Grenfell BT et al. Intracellular demography and the dynamics of Salmonella enterica infections. PLoS Biol 2006; 4: e349.

    Article  PubMed  PubMed Central  Google Scholar 

  41. Gadi VK, Alexander SD, Waud WR, Allan PW, Parker WB, Sorscher EJ . A long-acting suicide gene toxin, 6-methylpurine, inhibits slow growing tumors after a single administration. J Pharmacol Exp Ther 2003; 304: 1280–1284.

    Article  CAS  PubMed  Google Scholar 

  42. Dunstan SJ, Simmons CP, Strugnell RA . In vitro and in vivo stability of recombinant plasmids in a vaccine strain of Salmonella enterica var. typhimurium. FEMS Immunol Med Microbiol 2003; 37: 111–119.

    Article  CAS  PubMed  Google Scholar 

  43. Lee CH, Wu CL, Shiau AL . Endostatin gene therapy delivered by Salmonellacholeraesuis in murine tumor models. J Gene Med 2004; 6: 1382–1393.

    Article  CAS  PubMed  Google Scholar 

  44. Platt J, Sodi S, Kelley M, Rockwell S, Bermudes D, Low KB et al. Antitumour effects of genetically engineered Salmonella in combination with radiation. Eur J Cancer 2000; 36: 2397–2402.

    Article  CAS  PubMed  Google Scholar 

  45. Mengesha A, Dubois L, Lambin P, Landuyt W, Chiu RK, Wouters BG et al. Development of a flexible and potent hypoxia-inducible promoter for tumor-targeted gene expression in attenuated Salmonella. Cancer Biol Ther 2006; 5: 1120–1128.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

We thank State Key Lab of Genetic Engineering of Fudan University for technical assistance. Thanks a lot to Professor Chaoqun Wu, Mr Jiachi Liu and Mr James Andrew Worley for hel** us to amend the article.

Author information

Authors and Affiliations

  1. Department of Genetics, State Key Lab of Genetic Engineering, Fudan University, Shanghai, China

    W Fu, H Lan, S Li, X Han, T Gao & D Ren

Authors
  1. W Fu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. H Lan
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. S Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. X Han
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. T Gao
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. D Ren
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to D Ren.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Fu, W., Lan, H., Li, S. et al. Synergistic antitumor efficacy of suicide/ePNP gene and 6-methylpurine 2′-deoxyriboside via Salmonella against murine tumors. Cancer Gene Ther 15, 474–484 (2008). https://doi.org/10.1038/cgt.2008.19

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/cgt.2008.19

  • Springer Nature America, Inc.

Keywords

This article is cited by

Search

Navigation